Actionable news
All posts from Actionable news
Actionable news in ENDP: Endo Health Solutions Inc.,

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Skyrockets Dispute Facing Class Action Lawsuit- Endo International (NASDAQ:ENDP), Eli Lilly and Company (NYSE:LLY)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) [Detail Analytic Report] jumped over 2.13% in early trading session as Glancy Prongay & Murray LLP publicized that a class action lawsuit has been filed on behalf of shareholders of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) who bought shares during February 28, 2014 to October 21, 2015, inclusive and have been damaged by the recent declines in the firm’s stock price. On October 14, 2015, in connection with concerns over the firm’s practice of purchasing drugs and dramatically increasing prices, the firm declared that it was subpoenaed by US prosecutors seeking information on its pricing decisions, drug distribution and patient assistance programs. The firm also disclosed that it had responded to a letter from US Democratic Senator Claire McCaskill about Valeant’s heart drugs Nitropress and Isuprel. On October 21, 2015, the firm was the subject of an analyst report published by Citron Research that accuses that Valeant is using pharmacies linked to Philidor to store inventory and record the deals as sales. The Citron Research report further alleges that it appears that Valeant/Philidor have created an entire network of phantom captive pharmacies to create counterfeit sales of drugs or to avoid scrutiny...